Early interim data from a Phase 2 clinical trial evaluating varying doses of a potential oral therapy, RG7916,…
Nicole Wetsman
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Nicole Wetsman
Infants with spinal muscular atrophy (SMA) continue to show better motor control and strength the longer they receive Spinraza…